Goldman Sachs Future Health Care Equity ETF Rating → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free GDOC Stock Alerts $33.64 -0.32 (-0.94%) (As of 01:05 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Goldman Sachs Future Health Care Equity ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GDOC Aggregate RatingModerate Buy2.70Holdings in GDOC have an aggregate rating of Moderate Buy based on 523 analyst ratings issued in the past year covering 38 companies (77.3% of the portfolio).GDOC Aggregate Price Target$38.9314.64% UpsideHigh Prediction$49.19Average Prediction$38.93Low Prediction$29.05Holdings in GDOC have an aggregate price target of $38.93 and a range of $29.05 to $49.19 covering 38 companies (77.3% of the portfolio).GDOC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Goldman Sachs Future Health Care Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 38 GDOC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.38%LLYEli Lilly and Company$776.11-0.2%5 of 5 stars2.84$757.95 -2.3%19Earnings ReportDividend Announcement6.01%BSXBoston Scientific$73.06-0.5%4 of 5 stars2.95$75.09 2.8%214.56%ISRGIntuitive Surgical$380.92-2.0%5 of 5 stars2.76$396.17 4.0%17Insider Selling4.14%ABBVAbbVie$160.14-1.5%4 of 5 stars2.77$174.31 8.8%13Earnings Report3.90%AMGNAmgen$304.08+1.3%5 of 5 stars2.52$305.05 0.3%21Earnings ReportAnalyst Revision3.62%DHRDanaher$248.48-0.1%5 of 5 stars2.64$267.31 7.6%14Dividend Announcement3.39%COOCooper Companies$92.17-1.3%3 of 5 stars2.80$109.48 18.8%103.34%ZBHZimmer Biomet$120.16-1.0%5 of 5 stars2.29$135.40 12.7%14Earnings ReportAnalyst Revision3.20%PODDInsulet$175.67-4.7%5 of 5 stars2.81$240.33 36.8%16Upcoming EarningsAnalyst UpgradeNews CoverageGap Down3.08%BIIBBiogen$220.59+0.8%5 of 5 stars2.65$290.92 31.9%26Positive News3.02%BMRNBioMarin Pharmaceutical$82.26-0.4%5 of 5 stars2.63$107.50 30.7%19Insider Selling2.76%NBIXNeurocrine Biosciences$139.25-2.8%5 of 5 stars2.74$147.88 6.2%23Analyst Revision2.23%MTDMettler-Toledo International$1,253.39+0.5%3 of 5 stars2.17$1,191.57 -4.9%6Upcoming Earnings2.01%AAgilent Technologies$142.05+0.6%4 of 5 stars2.59$141.29 -0.5%171.78%DXCMDexCom$128.22-1.4%5 of 5 stars2.93$141.67 10.5%141.71%SWAVShockwave Medical$330.420.0%5 of 5 stars2.09$309.11 -6.4%11Earnings Report1.70%IDXXIDEXX Laboratories$484.51+0.2%4 of 5 stars2.67$580.88 19.9%9Positive News1.47%HUMHumana$322.98-0.5%5 of 5 stars2.47$424.50 31.4%191.39%ARGXargenx$384.24-3.7%3 of 5 stars2.71$528.16 37.5%21Upcoming EarningsNews Coverage1.38%EXASExact Sciences$60.23-1.9%4 of 5 stars2.92$99.07 64.5%13Positive News1.32%WSTWest Pharmaceutical Services$365.00-0.9%5 of 5 stars2.80$435.20 19.2%5Positive News1.31%VEEVVeeva Systems$203.76-0.8%5 of 5 stars2.65$234.90 15.3%20Positive News1.29%ALGNAlign Technology$269.64-5.9%5 of 5 stars2.50$353.00 30.9%10Positive News1.12%EWEdwards Lifesciences$84.86-1.1%5 of 5 stars2.56$93.27 9.9%18Analyst ForecastPositive News0.77%GMABGenmab A/S$28.76-1.8%3 of 5 stars2.38$48.50 68.6%13Gap Down0.69%ALNYAlnylam Pharmaceuticals$154.91+0.4%5 of 5 stars2.59$216.19 39.6%17Earnings ReportAnalyst Forecast0.60%ROIVRoivant Sciences$11.03-3.1%4 of 5 stars2.90$16.90 53.2%10Positive News0.60%RAREUltragenyx Pharmaceutical$41.06-2.1%4 of 5 stars2.92$87.85 113.9%12Earnings ReportAnalyst Forecast0.54%NTRANatera$95.29-1.9%2 of 5 stars3.00$86.40 -9.3%14Upcoming Earnings0.51%XENEXenon Pharmaceuticals$42.57-2.0%3 of 5 stars3.00$59.44 39.6%9Upcoming EarningsNews CoveragePositive News0.50%IRTCiRhythm Technologies$100.33-5.5%1 of 5 stars3.00$134.00 33.6%70.48%MLTXMoonLake Immunotherapeutics$41.90-4.0%2 of 5 stars2.75$74.46 77.7%12Earnings ReportUpcoming EarningsAnalyst ForecastNews Coverage0.47%ILMNIllumina$109.68-2.8%5 of 5 stars2.30$164.65 50.1%20Earnings ReportAnalyst ForecastAnalyst Revision0.44%STVNStevanato Group€26.96-2.5%0 of 5 stars2.717Upcoming Earnings0.43%PCVXVaxcyte$66.25-1.9%1 of 5 stars3.00$78.50 18.5%4Upcoming Earnings0.43%DYNDyne Therapeutics$25.08-2.2%4 of 5 stars3.13$37.75 50.5%8Analyst ForecastAnalyst RevisionNews Coverage0.37%ITCIIntra-Cellular Therapies$67.84-4.7%5 of 5 stars2.90$90.17 32.9%10Earnings ReportAnalyst ForecastNews Coverage0.35%CGONCG Oncology$31.20-8.1%1 of 5 stars2.75$61.75 97.9%4Analyst Forecast This page (NYSEARCA:GDOC) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs Future Health Care Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
